SGX Group has divested its wholly owned subsidiary, Scientific Beta, to STOXX Ltd.

SGX explained it is prioritising investments that strengthen its multi-asset franchise and long-term growth trajectory, particularly in areas that are integral to its securities, derivatives and data businesses.

This agreement secures an outcome that positions Scientific Beta for its next phase of growth. Under new ownership, it will be well-equipped to advance its research-driven capabilities and expand its global reach.

Following the transaction, SGX will retain its global multi-asset iEdge platform and continue to build on its index business as part of its broader multi-asset offering.

Ng Yao Loong, Head of Global Financial Markets, SGX Group, said:

“We are pleased to transition Scientific Beta to a new owner well-positioned to scale its capabilities and distribution. This divestment allows SGX to focus on areas where we see the strongest opportunities to deliver impact for our clients, partners and shareholders, and to further strengthen our multi-asset offering.”